Vasa Denticity Ltd
Vasa Denticity Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Dentalkart aspires to double revenues every 3 to 4 years, aiming for significant growth in the long term. Management expects significant operating leverage leading to improved operating margins as revenue grows (Page 21).
From Vasa Denticity Ltd's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Dentalkart aspires to double revenues every 3 to 4 years, aiming for significant growth in the long term.
- There is a large untapped "wallet share" within the current customer base, with potential for up to 10x growth in some states.
- Focus on improving core areas—better customer service, faster delivery in key regions, and expanding assortments to include more categories—will drive multi-fold growth.
- Operating leverage is expected as revenue grows, with manpower and warehouse costs not increasing proportionally, improving profitability.
- Plans to scale SKU count from 23,000 to 35,000 reflect expansion into unmet categories.
2 more points from Vasa Denticity Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Vasa Denticity Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Currently, no immediate plans for large capital investment or acquisition, as the company recently decided not to proceed with a planned acquisition after 9 months of integration efforts.
- Plans to optimize existing warehouses rather than aggressively opening new ones now; considering smaller warehouses (dark stores of 500-1,000 sq ft) in smaller cities for faster delivery in the future.
- Future investments may prioritize enhancing technology such as AI-driven recommendation and search engines, improving supply chain, and customer service systems.
- Cash on the balance sheet is planned to be parked and used as growth capital over the years, with no immediate large-scale investment plans.
2 more points from Vasa Denticity Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vasa Denticity Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Vasa Denticity Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Vasa Denticity Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹72 Cr, net profit ₹1 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vasa Denticity Ltd's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Q-Line Biotech Ltd (Q4 FY26)
Shift towards more manufacturing with gross margins of 60-65% for reagents supporting profitability improvement (Page 7, 6). Key concall takeaways from Q-Line…
- QMS Medical Allied Services Ltd (Q4 FY26)
INR 13 crores in FY26 to INR 18-20 crores in FY27. Key concall takeaways from QMS Medical's Q4 FY26 earnings call — and how it ranks against sector peers.
- Tarsons Products Ltd (Q4 FY26)
Margins may face pressure short-term due to raw material price volatility but should stabilize around current levels (gross margin not below 65%). Key concall…
- Laxmi Dental Ltd (Q4 FY26)
Export revenue (currently 33-34%) has tremendous potential alongside domestic; focus will be opportunity-driven (Page 11). Key concall takeaways from Laxmi…
Arthneeti Pro · Annual
Vasa Denticity Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vasa Denticity Ltd Q4 FY26 results?
Dentalkart aspires to double revenues every 3 to 4 years, aiming for significant growth in the long term. Management expects significant operating leverage leading to improved operating margins as revenue grows (Page 21).
What is Vasa Denticity Ltd share price analysis?
Vasa Denticity Ltd currently shows a neutral. The stock trades at a P/E of 62.4 with a market cap of ₹673 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vasa Denticity Ltd planning capital expenditure?
Currently, no immediate plans for large capital investment or acquisition, as the company recently decided not to proceed with a planned acquisition after 9 months of integration efforts.
Keep Vasa Denticity Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.